Patent 9920120 was granted and assigned to Genentech on March, 2018 by the United States Patent and Trademark Office.
Purified recombinant polypeptides isolated from Chinese hamster ovary host cells, including antibodies, such as therapeutic antibodies, and methods of making and using such polypeptides are provided.